Lumiera Health Inc.
NHPHF
OTC PK
| 08/31/2023 | 05/31/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -11.48% | 35.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -11.48% | 35.43% | |||
| Cost of Revenue | -5.81% | 488.61% | |||
| Gross Profit | -23.32% | -48.02% | |||
| SG&A Expenses | -7.50% | 19.43% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.54% | 84.22% | |||
| Operating Income | -3.13% | -526.79% | |||
| Income Before Tax | 1.22% | -72.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.22% | -72.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.22% | -72.73% | |||
| EBIT | -3.13% | -526.79% | |||
| EBITDA | -3.40% | -1,017.24% | |||
| EPS Basic | 0.00% | -50.00% | |||
| Normalized Basic EPS | 0.00% | -100.00% | |||
| EPS Diluted | 0.00% | -50.00% | |||
| Normalized Diluted EPS | 0.00% | -100.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
